Lupin appoints Dr Ranjana Pathak as chief quality officer

Dr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla, Watson/Actavis, and Endo Pharmaceuticals. Lupin invests in R&D.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/40PQcrC
via IFTTT

Read More

Aster DM completes separation of Gulf business, plans to add 1,700 beds in India in next 3 years

Aster DM Healthcare has finalized the separation of its India and Gulf (GCC) businesses. A consortium led by Fajr Capital acquired a 65% stake in Aster GCC, while the Moopen family retained 35%. In India, the family holds a 41.88% stake. The separation aims to enhance strategic and financial flexibility.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/25T4zED
via IFTTT

Read More

General Atlantic buys hospital chain Ujala Cygnus

General Atlantic acquires Ujala Cygnus for Rs1600 crore, with existing investors exiting fully. Ujala Cygnus to enhance infrastructure and care quality. Probal Ghosal and Shantanu Rastogi commend the company's achievements.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VMxwpkY
via IFTTT

Read More

Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supply

Bharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Institute of India, to strengthen production and supply security of oral polio vaccines. An agreement has been signed between the two partners under which Bharat Biotech will procure drug substances for the production of oral polio vaccines (OPVs) to be supplied within India and globally, the company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nLyb7Np
via IFTTT

Read More

India all set to make Penicillin G after three decades on PLI push

India stopped producing the two input drugs about three decades ago and since then it has relied on China for their supplies. "As of now, we are largely dependent on China. With the initiative of the production-linked-incentive scheme, companies like Aurobindo are coming up with fermentation-based products like PenG," said Ravi Uday Bhaskar, director general, Pharmaceutical Export Promotion Council (Pharmexcil). "We will be in a better position in the coming few months."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4eMAOZz
via IFTTT

Read More

Mubadala plans big deals in India's healthcare space

Abu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a focus on pharmaceuticals, outsourced pharma services, and medtech, Mubadala aims to deploy capital meaningfully in India. This move aligns with Mubadala's strategy to generate sustainable financial returns. They have made significant investments globally and are now looking to expand their presence in India's healthcare landscape.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NuwPCDA
via IFTTT

Read More

Alembic Pharma gets tentative USFDA nod for breast cancer drug

The medicine is indicated for the treatment of adult patients with a certain type of advanced or metastatic breast cancer in a combination of drug therapy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u6KXnL8
via IFTTT

Read More